Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

RAJIV AGARWAL

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1154386258
CMS profile
142656
Location
INDIANAPOLIS, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$252,649.68

110 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $224,591.82 53
Travel and Lodging $26,086.05 32
Food and Beverage $1,971.81 25

By paying entity

PY2024 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

RAJIV AGARWAL

NPI 1154386258 · CMS profile ID 142656

Allopathic & Osteopathic Physicians / Internal Medicine / Nephrology

INDIANAPOLIS, IN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1154386258?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
RAJIV AGARWAL, NPI 1154386258, CMS profile ID 142656. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1154386258?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). RAJIV AGARWAL, NPI 1154386258, CMS profile ID 142656. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1154386258?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
RAJIV AGARWAL, NPI 1154386258, CMS profile ID 142656, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1154386258?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

110 matching records · $252,649.68 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 110 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 110.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $210.9007/12/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777553 CMS
Novartis Pharmaceuticals Corporation $42.2107/12/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777555 CMS
Novartis Pharmaceuticals Corporation $7,650.0007/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777557 CMS
Novartis Pharmaceuticals Corporation $39.0007/12/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777559 CMS
VERTEX PHARMACEUTICALS INCORPORATED $300.0007/11/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105904174 CMS
VERTEX PHARMACEUTICALS INCORPORATED $600.0007/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105919352 CMS
Alexion Pharmaceuticals, Inc. $22,780.0006/24/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094001680 CMS
VERTEX PHARMACEUTICALS INCORPORATED $1,800.0006/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105917952 CMS
Alnylam Pharmaceuticals Inc. $437.5006/13/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125857360 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,642.5006/03/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086137393 CMS
VERTEX PHARMACEUTICALS INCORPORATED $1,200.0005/23/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105915218 CMS
VERTEX PHARMACEUTICALS INCORPORATED $300.0005/23/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105920063 CMS
VERTEX PHARMACEUTICALS INCORPORATED $190.3505/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105906137 CMS
VERTEX PHARMACEUTICALS INCORPORATED $13,500.0005/22/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105910440 CMS
VERTEX PHARMACEUTICALS INCORPORATED $141.9505/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105912498 CMS
VERTEX PHARMACEUTICALS INCORPORATED $413.2005/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105917308 CMS
VERTEX PHARMACEUTICALS INCORPORATED $1,275.3805/22/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105921409 CMS
Novartis Pharmaceuticals Corporation $182.6005/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086759643 CMS
Novartis Pharmaceuticals Corporation $608.8405/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086759645 CMS
Novartis Pharmaceuticals Corporation $228.1005/20/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086759647 CMS
Novartis Pharmaceuticals Corporation $447.4105/19/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086759641 CMS
Alnylam Pharmaceuticals Inc. $2,875.0005/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125857354 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,500.0005/08/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086137389 CMS
Alexion Pharmaceuticals, Inc. $76.9305/02/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093901940 CMS
VERTEX PHARMACEUTICALS INCORPORATED $26,758.2705/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105906851 CMS
VERTEX PHARMACEUTICALS INCORPORATED $600.0005/02/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105914548 CMS
Alexion Pharmaceuticals, Inc. $33.4905/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093951677 CMS
Alexion Pharmaceuticals, Inc. $49.7504/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093954064 CMS
Alexion Pharmaceuticals, Inc. $33.5304/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093979812 CMS
Alexion Pharmaceuticals, Inc. $38.3904/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094027406 CMS
Alexion Pharmaceuticals, Inc. $63.3804/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093909418 CMS
Alexion Pharmaceuticals, Inc. $155.2004/29/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1094008440 CMS
Alexion Pharmaceuticals, Inc. $8,280.8004/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093909486 CMS
Alexion Pharmaceuticals, Inc. $1,077.2204/28/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1093913758 CMS
Boehringer Ingelheim International GmbH $15.9004/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117893755 CMS
Boehringer Ingelheim International GmbH $30.0004/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117893759 CMS
Boehringer Ingelheim International GmbH $75.0004/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117893769 CMS
Boehringer Ingelheim International GmbH $194.0004/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117893771 CMS
Boehringer Ingelheim International GmbH $8,842.5704/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117893777 CMS
Alnylam Pharmaceuticals Inc. $4,187.5004/12/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125857340 CMS
VERTEX PHARMACEUTICALS INCORPORATED $16,387.9303/21/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105907597 CMS
Bayer Healthcare Pharmaceuticals Inc. $1,200.0003/20/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086107726 CMS
Alnylam Pharmaceuticals Inc. $6,625.0003/14/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125857336 CMS
VERTEX PHARMACEUTICALS INCORPORATED $300.0002/29/2024 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1105913174 CMS
Novartis Pharmaceuticals Corporation $185.8102/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777533 CMS
Novartis Pharmaceuticals Corporation $62.6902/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777535 CMS
Novartis Pharmaceuticals Corporation $215.7602/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777537 CMS
Novartis Pharmaceuticals Corporation $557.2502/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777539 CMS
Novartis Pharmaceuticals Corporation $40.0002/23/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1086777541 CMS
Novartis Pharmaceuticals Corporation $9,637.5002/23/2024 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1155561983 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $179,551.13 103
PY2020 $95,321.61 55
PY2021 $105,037.04 54
PY2022 $224,521.53 118
PY2023 $84,960.52 45
PY2024 $252,649.68 110
PY2025 $275,828.26 84

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $33,350.00 14
PY2024 Recipient $150,793.50 17
PY2023 Recipient $34,610.00 31
PY2022 Recipient $75,920.00 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient Novartis Pharmaceuticals Corporation $7,800.00 12/16/2025 Covered Recipient Physician A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function No dispute reported 06/30/2026 1190291222
Recipient Intercept Pharmaceuticals, Inc. $750.00 12/15/2025 Covered Recipient Physician A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis No dispute reported 06/30/2026 1248170886
Recipient Bayer Healthcare Pharmaceuticals Inc. $480.00 12/01/2025 Covered Recipient Physician Study 21177 Finerenone No dispute reported 06/30/2026 1225400762
Recipient Intercept Pharmaceuticals, Inc. $250.00 11/15/2025 Covered Recipient Physician A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis No dispute reported 06/30/2026 1248170888
Recipient Intercept Pharmaceuticals, Inc. $250.00 09/15/2025 Covered Recipient Physician A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis No dispute reported 06/30/2026 1248170884
Recipient Intercept Pharmaceuticals, Inc. $2,437.50 08/15/2025 Covered Recipient Physician A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-escalation, Proof-of-Concept Study Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetics of INT-787 in Subjects With Severe Alcohol Associated Hepatitis No dispute reported 06/30/2026 1248170882
Recipient Bayer Healthcare Pharmaceuticals Inc. $480.00 06/20/2025 Covered Recipient Physician Study 21177 Finerenone No dispute reported 06/30/2026 1225400756
Recipient Novartis Pharmaceuticals Corporation $6,000.00 05/16/2025 Covered Recipient Physician A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function No dispute reported 06/30/2026 1190293064
Recipient Intercept Pharmaceuticals, Inc. $4,625.00 05/15/2025 Covered Recipient Physician FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study (FRESH) No dispute reported 06/30/2026 1248170880
Recipient Intercept Pharmaceuticals, Inc. $1,000.00 04/15/2025 Covered Recipient Physician FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study (FRESH) No dispute reported 06/30/2026 1248170878
Recipient Intercept Pharmaceuticals, Inc. $3,937.50 03/12/2025 Covered Recipient Physician FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study (FRESH) No dispute reported 06/30/2026 1248170876
Recipient Bayer Healthcare Pharmaceuticals Inc. $480.00 02/14/2025 Covered Recipient Physician Study 21177 Finerenone No dispute reported 06/30/2026 1225400760
Recipient Bayer Healthcare Pharmaceuticals Inc. $360.00 01/13/2025 Covered Recipient Physician Study 21177 Finerenone No dispute reported 06/30/2026 1225400758
Recipient Intercept Pharmaceuticals, Inc. $4,500.00 01/08/2025 Covered Recipient Physician Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE) No dispute reported 06/30/2026 1248170874